↓ Skip to main content

A Neonatal Amikacin Covariate Model Can Be Used to Predict Ontogeny of Other Drugs Eliminated Through Glomerular Filtration in Neonates

Overview of attention for article published in Pharmaceutical Research, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
73 Mendeley
Title
A Neonatal Amikacin Covariate Model Can Be Used to Predict Ontogeny of Other Drugs Eliminated Through Glomerular Filtration in Neonates
Published in
Pharmaceutical Research, September 2013
DOI 10.1007/s11095-013-1197-y
Pubmed ID
Authors

Roosmarijn F. W. De Cock, Karel Allegaert, Catherine M. T. Sherwin, Elisabet I. Nielsen, Matthijs de Hoog, Johannes N. van den Anker, Meindert Danhof, Catherijne A. J. Knibbe

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 2 3%
United States 1 1%
Unknown 70 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 21%
Student > Bachelor 11 15%
Student > Master 10 14%
Researcher 6 8%
Student > Postgraduate 4 5%
Other 8 11%
Unknown 19 26%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Pharmacology, Toxicology and Pharmaceutical Science 17 23%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 9 12%
Unknown 22 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2017.
All research outputs
#12,937,099
of 23,002,898 outputs
Outputs from Pharmaceutical Research
#2,084
of 2,870 outputs
Outputs of similar age
#101,838
of 203,942 outputs
Outputs of similar age from Pharmaceutical Research
#21
of 30 outputs
Altmetric has tracked 23,002,898 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,870 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,942 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.